Acute bronchitis: topical issues of epidemiology, etiology, pharmacotherapy and prevention


DOI: https://dx.doi.org/10.18565/epidem.2019.9.2.75-80

Zaitsev A.A., Akimkin V.G.

1) Academician N.N. Burdenko Main Military Clinical Hospital, Ministry of Defense of the Russian Federation, Moscow, Russia; 2) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
The review is devoted to the issues of epidemiology, pharmacotherapy and prevention of acute bronchitis (AB) in adults. The data on the prevalence of the disease in different countries, modern ideas about the etiology of the AB, directions of pharmacotherapy are given. It is emphasized that AB is a disease of predominantly viral etiology, and the use of antimicrobial drugs in initial treatment regimens is wrong. A critical analysis of the use of various drugs for the treatment of AB from the standpoint of evidence-based medicine, including the possibility of antiviral therapy, as well as recommendations for vaccination is presented.
Keywords: vaccine prophylaxis, acute bronchitis, antiviral therapy, diagnosis, epidemiology
Read entire article

Literature

  1. Bartlett J., Dowell S., Mandell L. et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis. 2000; 31: 347–82.
  2. Wenzel R., Fowler A. Acute Bronchitis. Clinical practice. N. Engl. J. Med. 2006; 355: 2125–30.
  3. Albert R. Diagnosis and treatment of acute bronchitis. Am. Fam. Physician 2010; 82(11): 1345–50.
  4. Zaytsev A.А. [Acute bronchitis: diagnosis and treatment]. Terapy 2017; (1): 31–5. (In Russ.).
  5. Worrall G. Acute bronchitis. Can. Fam. Physician 2008; 54 (2): 238–9.
  6. Knutson D., Braun C. Diagnosis and management of acute bronchitis. Am. Fam. Physician 2002; 65(10): 2039–44.
  7. Renati S., Linder J. Necessity of office visits for acute respiratory infections in primary care. Fam Pract. 2016; 33(3): 312–7.
  8. Wark P. Bronchitis (acute). BMJ Clin. Evid. 2015; (7): 1508. https://www. ncbi.nlm.nih.gov/pmc/articles/PMC4505629/
  9. Meza R.A., Bridges-Webb C., Sayer G.P., Miles D.A., Traynor V., Neary S. The management of acute bronchitis in general practice: results from the Australian morbidity and treatment survey. Aust. Fam. Physician 1994: 23: 1550–3.
  10. Li X., Li J., Meng L. et al. Viral etiologies and epidemiology of patients with acute respiratory infections based on sentinel hospitals in Gansu Province, Northwest China 2011–2015. J. Med. Virol. 2018; 90(5): 828–35.
  11. Muñoz F., Carvalho M. Effect of exposure time to PM (10) on emergency admissions for acute bronchitis. Cad. Saude Publica 2009; 25(3): 529–39.
  12. Ott S., Rohde G., Lepper P., Hauptmeier B., Bals R., Pletz M.W.R. et al. The impact of viruses in lower respiratory tract infections of the adult. Part II: acute bronchitis, acute exacerbated COPD, pneumonia, and influenza. Pneumologie 2010; 64(1): 18–27.
  13. Wadowsky R., Castilla E., Laus S., Kozy A., Atchison R.W., Kingsley L.A. et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J. Clin. Microbiol. 2002; 40: 637–40.
  14. Meili M., Kutz A., Briel M. et al. Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein. BMC Pulm. Med. 2016; 16: 43. https://www.ncbi.nlm.nih.gov/pubmed/27009083
  15. Zaitsev А.А., Ovchinnikov Y.V., Kondratieva T.V. [Biological markers of inflammation in community-acquired pneumonia]. Consilium Medicum 2014; 16(11): 36–41. (In Russ.).
  16. Franck A., Smith R. Antibiotic use for acute upper respiratory tract infections in a veteran population. J. Am. Pharm. Assoc. 2010; 50(6): 726–9.
  17. Smith S., Fahey T., Smucny J., Becker L. Antibiotics for acute bronchitis. Cochrane Database Syst. Rev. 2014; 1(3): CD000245. DOI: 10.1002/14651858.CD000245.pub3.
  18. Zaytsev A.A., Kulagina I.С. [Pharmacotherapy of acute bronchitis]. Consilium Medicum 2012; 14(11): 16–21. (In Russ.).
  19. Lior C., Moragas A., Bayona C., Morros R., Pera H., Cots J., Fernández Y., Miravitlles M., Boada A. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm. Med. 2011; 11: 38–47.
  20. Smucny J., Fahey T., Becker L., Glazier R., McIsaac W. Antibiotics for acute bronchitis. Cochrane Database Syst. Rev. 2000; (4): CD000245.
  21. Barlett J. Respiratory Tract Infections. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
  22. Zaitsev A.A., Kulagina I.С. [Pharmacotherapy of acute bronchitis in clinics: results of pharmacoepidemical research]. Value in Health 2012; 15(7): A386.
  23. Zaytsev A.A., Gorelov A.V., Klochkov O.I. [Acute respiratory viral infections: antiviral therapy perspectives]. Vestnik semeynoy meditsiny 2009; (5): 18. (In Russ.).
  24. Jefferson T., Tyrrell D. Antivirals for the common cold. The Cochrane Database Syst. Rev. 2005; (3): CD002743.
  25. Zaytsev A.A., Kulagina I., Peredelskii S.V., Alpenidze D.N. [Modern possibilities of pharmacotherapy of acute bronchitis]. Voyenno-meditsinskiy zhurnal 2011; 332(10): 39–44. (In Russ.).
  26. Malyshev N.А., Kolobuhina L.V., Merkulova L.N., Ershov F.I. [Modern approaches to increasing the effectiveness of therapy and prevention of influenza and other acute respiratory viral infections]. Consilium Medicum 2005; 10 (7): 831–5. (In Russ.).
  27. Zaytsev A.A., Sinopalnikov A.I. [Rational pharmacotherapy of acute respiratory viral infections]. Consilium Medicum 2008; 10(10): 80–6. (In Russ.).
  28. Zaytsev A.A., Okovityi S.V. [Cough: differential diagnosis and pharmacotherapy]. Terapevticheskiy Archive 2014; (12): 85–91. (In Russ.).
  29. Smucny J., Flynn C., Becker L., Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst. Rev. 2004; (1): CD001726.
  30. Zaytsev A.А. [Directions of pharmacotherapy and prevention of acute respiratory viral infections]. Russkiy meditsinskiy zhurnal 2009; 17(23): 1525–9. (In Russ.).


About the Autors

Prof. Andrey A. Zaytsev, MD, Principal Pulmonologist, Academician N.N. Burdenko Main Military Clinical Hospital; Principal Pulmonologist, Ministry of Defense of the Russia, Моscow, Russia; е-mail: a-zaicev@yandex.ru; ОRCID: http://orcid.org/0000-0002-0934-7313
Prof. Vasiliy G. Akimkin, MD, Аcademician of the Russian Academy of Sciences, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: vgakimkin@yandex.ru; ОRCID: http://orcid.org/0000-0003-4228-9044


Similar Articles

Back to Content

Бионика Медиа